Home | Welcome to Contract Pharma   
Last Updated Friday, May 24 2013
Print RSS Feed

Breaking News

Related Searches: Promotions & Moves •
Laxai Pharma

August 13, 2010
Naren Mallakunta has been named chief executive officer of Laxai Pharma, Ltd., joining the company's management team.   Read More »
Ricerca Biosciences

August 12, 2010
Carlos Martínez Manchado has joined the Analytical Chemistry department at Ricerca Biosciences.   Read More »
Genzyme: Allston Fixes To Take Years

August 12, 2010
Genzyme Corp. expects changes requested by the FDA after a contamination at its Allston plant to take as many as four years longer than previously projected.  Read More »
CLC, PSSC Offer New Full-Genome Data Solution

August 12, 2010
CLC bio and PSSC Labs introduced a new solution, CLC Genomics Factory, for assembly, read mapping, and subsequent downstream analysis of very large amounts of high-throughput DNA and RNA sequencing data.  Read More »
NextWave, Tris Enter CNS Pact

August 12, 2010
NextWave Pharmaceuticals and Tris Pharma have entered a collaboration agreement under which Tris Pharma will use its drug delivery technology for liquid and solid formulations to enhance NextWave's CNS product portfolio.  Read More »
WuXi PharmaTech

August 12, 2010
Edward Hu has been appointed chief financial officer of WuXi PharmaTech, effective immediately.   Read More »
Merck Reacquires Cherokee Plant

August 11, 2010
Merck Sharp & Dohme Co. has reacquired the Cherokee Pharmaceutical plant that was previously sold to PRWT Services, Inc. more than two years ago. Details of the transaction were not disclosed.  Read More »
Sanofi-Aventis Selects SCM for Radio-Labelled Product

August 11, 2010
Sanofi-Aventis has selected SCM Pharma for the fast-tracked fill/finish of a radio-labelled product.   Read More »
Xcelience Adds Minipress

August 11, 2010
Xcelience has expanded its formulation development and manufacturing capabilities with the addition of a Piccola B10 Minipress.   Read More »
Sanofi-Aventis Enters Genomic Drug Alliance

August 10, 2010
Sanofi-Aventis and Scripps Genomic Medicine (SGM) entered a strategic alliance to advance R&D initiatives in the field of personalized medicine.  Read More »
Scancell Licenses CRT Antibody

August 10, 2010
Scancell Holdings and Cancer Research Technology, Ltd. (CRT) have signed an agreement under which Scancell has been granted a license to use a human antibody known as 105AD7.  Read More »
Financial Report: PAREXEL 4Q

August 10, 2010
Clinical Research Services revenue in the quarter was $225.4 million (+11%).  Read More »
Elan, Transition Therapeutics Advance Alzheimer’s Drug

August 10, 2010
Elan Corp. and Transition Therapeutics, Inc reported results from a Phase II study of ELND005 (Scyllo-inositol) in patients with mild to moderate Alzheimer’s disease.  Read More »
YM BioSciences JAK1/2 Inhibitor Gets Orphan Designation

August 10, 2010
YM BioSciences’ highly selective JAK1/2 inhibitor, CYT387 has been granted Orphan Drug Designation.   Read More »
Kendle

August 9, 2010
Michael J. Gallagher, M.D., has been appointed vice president and Global Head of Medical Affairs at Kendle.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: